Nodify Lung® Tests (XL2 & CDT)

About Biodesix

Biodesix is a publicly-traded diagnostic company with a mission to transform patient care through timely, personalized diagnostics, primarily in lung cancer. The company has successfully commercialized a suite of blood-based tests, including the FDA-cleared Nodify Lung® and GeneStrat® tests, which are supported by its proprietary AI-driven multi-omics platform and real-world Biodesix Lung Database®. Its strategy is twofold: expanding the clinical adoption of its diagnostic tests while capitalizing on its platform and operational expertise through a growing diagnostic development services business for life sciences partners.

Therapeutic Areas